CY, W., A, S., JD, E., PP, L., MK, K., N, H., . . . BR, S. (2026). Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: A cohort study of older adults with diabetes. Diabetologia, 69(2), 386. https://doi.org/10.1007/s00125-025-06595-0
Chicago Style (17th ed.) CitationCY, Wu, et al. "Cardiovascular Effectiveness and Safety of SGLT2 Inhibitors Vs DPP4 Inhibitors by Dementia Status: A Cohort Study of Older Adults with Diabetes." Diabetologia 69, no. 2 (2026): 386. https://doi.org/10.1007/s00125-025-06595-0.
MLA (9th ed.) CitationCY, Wu, et al. "Cardiovascular Effectiveness and Safety of SGLT2 Inhibitors Vs DPP4 Inhibitors by Dementia Status: A Cohort Study of Older Adults with Diabetes." Diabetologia, vol. 69, no. 2, 2026, p. 386, https://doi.org/10.1007/s00125-025-06595-0.